GEOGRAPHICAL COVERAGE With more than 1.3 billion people, or one-fifth of the world's total population, China is a dream market for pharmaceuticals. However, among the early entrants, their business results to date have been mixed. Many companies have leapt into China with high hopes, only to beat a quiet retreat later on. Why? In addition to a variety of uncertainties that normally surround entry into a new country market, one factor that makes entry into China an even more difficult challenge is the complexity of China's population, geography, history, and recent economic development. China is not only the world's most populous nation, it also possesses a massive land area - roughly the size of the U.S. To complicate matters further, China's population density, economic development, and wealth distribution vary greatly from east to west, and from south to north. Up until the turn of the last century, economic development and wealth accumulation were largely confined to China's eastern seacoast, especially in southeastern China, where 20 percent of the country's population generated half of the nation's GDP and three-quarters of its total exports at one point in time. China population of 1.3 billion people is a lucrative market, of which 35% of it make up the urban population. Branded pharmaceutical products focus on the urban population found largely in the capital cities of each province. Health Vision Enterprise (HVE) with its own sales team focus on the urban population covering approximately 55 of the largest cities. As the brand develops across the fragmented market, a demand is generated in the smaller cities and rural areas. In such areas, Health Vision forms co operative agreements with credible local partners for market development. With this distribution network, HVE covers the potential China market effectively. << Click here for more >>